SCHEMBL660868

SCHEMBL660868

CC(=O)CN1C=CCC(C(=O)NCCO)=C1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.33
MEN1 O00255 1/20 0.32
CACNA1B Q00975 1/20 0.32
APBA1 Q02410 1/20 0.32
KMT2A Q03164 1/20 0.32
ALDH1A1 P00352 4/20 0.32
KDM4E B2RXH2 2/20 0.32
MAPT P10636 1/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
MMP13 P45452 1/20 0.31
HPGD P15428 2/20 0.31
GAA P10253 1/20 0.31
HIF1A Q16665 1/20 0.31
CA12 O43570 2/20 0.31
CA1 P00915 2/20 0.31
CA2 P00918 2/20 0.31
CA9 Q16790 2/20 0.31
CA14 Q9ULX7 2/20 0.31
HTT P42858 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL658611 0.84 CA12 (0.32) LMNAMEN1CACNA1BAPBA1KMT2A
SCHEMBL14067679 0.80 LMNA (0.38) LMNAMEN1CACNA1BAPBA1KMT2A
SCHEMBL659968 0.79 TSHR (0.37) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL27573191 0.69 HPGD (0.33) LMNAALDH1A1KDM4EMMP13HPGD
SCHEMBL287649 0.64 GRIN2B (0.38) LMNAALDH1A1HPGDGAACYP2C19
SCHEMBL9011348 0.62 RAB9A (0.51) ALDH1A1KDM4EMAPTHPGDGAA
SCHEMBL11910903 0.61 ALDH1A1 (0.42) MEN1CACNA1BAPBA1KMT2AALDH1A1
SCHEMBL12963310 0.60 MAOB (0.42) MEN1KMT2AALDH1A1KDM4EHTT
SCHEMBL10523632 0.59 HTT (0.40) LMNAALDH1A1KDM4EMAPTCASP1
SCHEMBL18667789 0.59 MMP13 (0.40) LMNAALDH1A1KDM4EMAPTCASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS DUTT CHAITANYA (IN) 2012-02-23 US claimed
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS DUTT CHAITANYA (IN) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS AGER, REN, AGT LMNA 123/4885MEN1 1455/4885CACNA1B 3031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.